Skip to main content
. 2021 Dec 23;8:798765. doi: 10.3389/fcvm.2021.798765

Table 1.

General characteristics of ischemic stroke patients and healthy controls in discovery stage.

IS (n = 150) Control (n = 50) p
Age (years) 60 (53–68) 57 (55–66) 0.696
Sex (male, N, %) 100 (66.7%) 31 (62.0%) 0.548
HBP (N, %) 100 (66.7%) 20 (40.0%) <0.001
DM (N, %) 47 (31.3%) 4 (8.0%) 0.001
Hyperlipidemia (N, %) 24 (16.0%) 24 (48.0%) <0.001
CAD (N, %) 28 (18.7%) 9 (18.0%) 0.916
Smoking (N, %) 74 (49.3%) 14 (28.0%) 0.008
Drinking (N, %) 59 (39.3%) 10 (20.0%) 0.013
Admission NIHSS 4 (2–7) NA NA
mRS at 3 months 2 (1–3) NA NA
SBP (mmHg) 142 (127–154) 130 (120–139) <0.001
DBP (mmHg) 83 (74–91) 80 (72–85) 0.074
WBC (×109/L) 6.6 (5.4–8.2) 5.8 (4.9–6.9) 0.016
Platelet (×109/L) 192.0 (148.0–225.8) 205.0 (164.2–233.5) 0.126
BUN (mmol/L) 5.0 (4.2–6.0) 4.6 (4.0–6.2) 0.784
UA (μmol/L) 337.0 (279.0–394.6) 354.0 (289.4–434.4) 0.191
Creatinine (μmol/L) 79.9 (68.0–89.0) 74.2 (67.2–83.8) 0.172
eGFR (ml/min per 1.73 m2) 84.9 (70.2–95.6) 91.0 (76.8–98.7) 0.231
TG (mmol/L) 1.6 (1.1–2.0) 1.6 (1.3–2.4) 0.374
TC (mmol/L) 4.1 (3.4–4.8) 4.9 (4.2–5.5) <0.001
HDLC (mmol/L) 1.02 (0.83–1.18) 1.23 (0.99–1.40) <0.001
LDLC (mmol/L) 2.4 (1.9–2.9) 3.1 (2.6–3.6) <0.001
FBG (mmol/L) 6.0 (5.1–7.8) 5.1 (4.7–5.8) 0.01
HbA1c (%) 6.0 (5.6–7.2) 5.8 (5.5–6.0) 0.114
Homocysteine (μmol/L) 13.4 (11.2–17.4) 12.8 (10.5–13.6) 0.042

IS, ischemic stroke; HBP, hypertension; DM, Diabetes mellitus; CAD, coronary artery disease; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; SBP, systolic blood pressure, DBP, diastolic blood pressure; WBC, white blood cell; BUN, blood urea nitrogen; UA, uric acid; eGFR, estimated glomerular filtration rate; TG, triglyceride; TC, total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density lipoprotein cholesterol; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin A1c.